According to Fortune Business Insights, the global Aortic Aneurysm Market was valued at USD 5.68 billion in 2025. The market is projected to grow from USD 6.41 billion in 2026 to USD 16.78 billion by 2034, exhibiting a CAGR of 12.78% during the 2026–2034 forecast period. The market is expanding due to the rising prevalence of cardiovascular disorders, an aging population, increasing adoption of minimally invasive vascular procedures, growing aneurysm screening initiatives, and continuous innovation in aortic stent graft and endovascular repair technologies.
Market Trends
A major trend shaping the Aortic Aneurysm Market is the transition from open surgical repair toward minimally invasive endovascular aneurysm repair procedures. Hospitals and vascular specialists are increasingly adopting endovascular approaches because they can reduce recovery periods and hospitalization time. Low-profile delivery systems and flexible stent graft platforms are also being developed to improve treatment for patients with complex anatomies.
Advanced imaging integration is another important trend. Healthcare providers are increasingly using imaging technologies to measure aneurysm size, evaluate rupture risk, and support treatment planning. Artificial intelligence and predictive analytics are also being integrated into aneurysm screening and clinical decision-making.
Personalized vascular therapy is gaining momentum as patient-specific graft systems and customized treatment planning become more advanced. Manufacturers are also investing in bioengineered graft materials designed to improve durability and reduce complications such as leakage.
Remote patient monitoring and digital follow-up systems are also emerging as important developments, particularly because patients often require long-term imaging surveillance following aneurysm repair.
For detailed market insights: https://www.fortunebusinessinsights.com/aortic-aneurysm-market-116233
Market Drivers
The rising prevalence of cardiovascular disorders is a major driver of market growth. Conditions such as hypertension, atherosclerosis, obesity, and smoking-related vascular disease increase the risk of aortic aneurysms. As the global elderly population grows, the number of individuals requiring screening and treatment is also increasing.
Greater awareness of aneurysm risks is encouraging earlier diagnosis and intervention. Healthcare systems are expanding screening programs for high-risk populations, particularly older adults with cardiovascular complications.
The growing preference for minimally invasive treatment is another key growth factor. Patients and physicians are increasingly interested in procedures that can reduce surgical trauma and shorten recovery times. This trend is encouraging hospitals to expand their endovascular treatment capabilities.
Technological advancements in stent grafts, catheter-based systems, imaging, and surgical navigation are further supporting market expansion. Improved reimbursement policies and government support for cardiovascular disease management programs are also contributing to demand.
However, high procedural costs and limited access to advanced healthcare infrastructure remain significant challenges, particularly in low- and middle-income regions. A shortage of trained vascular specialists and limited access to advanced imaging systems can also restrict treatment availability.
Market Segmentation
By Type
The market is segmented into thoracic aortic aneurysm and abdominal aortic aneurysm.
Abdominal aortic aneurysm accounted for approximately 58% of the market. Its higher prevalence among elderly individuals, smokers, and patients with a history of cardiovascular disease supports segment growth. The increasing adoption of endovascular repair and advanced abdominal stent grafts is also contributing to demand.
Thoracic aortic aneurysm accounted for nearly 42% of the market. Growing awareness of hypertension-related vascular disorders and genetic connective tissue diseases is supporting demand. Branched and fenestrated stent grafts are increasingly being used to manage complex thoracic anatomies.
By Treatment
Open surgical repair accounted for nearly 36% of the market. It remains important for patients with complex aneurysm anatomy, severe calcification, or unsuitable vascular access for endovascular treatment.
Hybrid procedures represented approximately 24% of the market. These procedures combine open surgical and endovascular techniques and are increasingly used for anatomically challenging aneurysms.
By Product
Aortic stent grafts dominated the product segment with nearly 68% market share. These devices are widely used in endovascular aneurysm repair procedures. Manufacturers are focusing on branched and fenestrated designs, low-profile delivery systems, improved sealing capabilities, and enhanced graft durability.
By End Use
Hospitals and specialty cardiac centers accounted for nearly 72% of the market. These facilities perform most aneurysm diagnosis, treatment, and post-operative monitoring procedures because they have advanced imaging equipment, hybrid operating rooms, and specialized vascular professionals.
Key Players
Major companies operating in the Aortic Aneurysm Market include Medtronic, W.L. Gore & Associates, Inc., Cook, MicroPort Scientific Corporation, Boston Scientific Corporation, Artivion Inc., Cardiatis, Endologix Inc., Braile Biomédica, Lombard Medical, and INVAMED.
Medtronic held approximately 28% of the market, while W.L. Gore & Associates, Inc. accounted for approximately 21%. Companies are focusing on advanced stent grafts, minimally invasive treatment systems, personalized vascular implants, imaging technologies, and improved delivery systems.
Regional Analysis
North America dominated the global market with approximately 41% share. The region benefits from advanced cardiovascular infrastructure, high awareness of aneurysm screening, strong adoption of minimally invasive procedures, and favorable reimbursement structures. The United States is a major innovation center for stent grafts, AI-supported imaging, robotic-assisted vascular surgery, and personalized treatment planning.
Europe accounted for nearly 29% of the market. Established healthcare systems, growing cardiovascular screening programs, and increasing adoption of minimally invasive procedures support regional growth. Germany represented approximately 26% of the European market, while the United Kingdom accounted for around 19%.
Asia-Pacific held approximately 22% of the global market. Improving healthcare infrastructure, increasing cardiovascular disease prevalence, aging populations, and rising adoption of advanced vascular procedures are supporting regional expansion. Japan represented approximately 31% of the Asia-Pacific market, while China accounted for nearly 37%.
The Rest of the World accounted for approximately 8% of the market. Healthcare modernization, international medical collaborations, and growing investment in specialized vascular facilities are creating opportunities in Latin America, the Middle East, and Africa.
Competitive Landscape
The competitive landscape is characterized by strong investment in minimally invasive vascular technologies, advanced stent graft systems, AI-assisted imaging, and patient-specific treatment solutions. Leading companies are focusing on improving graft flexibility, sealing performance, durability, and delivery systems.
Recent innovation has included enhanced thoracic stent graft systems, upgraded abdominal graft configurations, AI-assisted vascular imaging, hybrid vascular surgery technologies, and expanded regional manufacturing capabilities. Strategic partnerships between medical device companies, hospitals, and research institutions are also supporting innovation.
Future Outlook
The future outlook for the Aortic Aneurysm Market remains highly positive. The increasing burden of cardiovascular disease, aging populations, improved screening, and growing adoption of minimally invasive procedures are expected to drive long-term expansion.
AI-assisted diagnostics, 3D imaging, personalized graft systems, robotic-assisted vascular surgery, and digital surgical planning are expected to shape future treatment pathways. Emerging economies are also likely to create significant opportunities as healthcare infrastructure and access to advanced cardiovascular treatment improve.
Manufacturers that can develop durable, flexible, low-profile, and patient-specific stent graft systems are expected to benefit from rising demand for advanced aneurysm treatment.
Get a free sample PDF: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/aortic-aneurysm-market-116233
Conclusion
The Aortic Aneurysm Market is undergoing significant transformation as healthcare providers increasingly adopt advanced diagnostic and minimally invasive treatment technologies. Rising cardiovascular disease prevalence, aging populations, improved screening, and technological innovation are driving market expansion.
Aortic stent grafts, endovascular procedures, AI-assisted imaging, hybrid surgery, and personalized vascular therapies are expected to remain important areas of development. Although high treatment costs, limited access in developing regions, and long-term monitoring requirements remain challenges, the market is projected to reach USD 16.78 billion by 2034. Continued investment in advanced vascular technologies and healthcare infrastructure will create significant opportunities across developed and emerging markets.
Frequently Asked Questions (FAQs)
1. What was the size of the Aortic Aneurysm Market in 2025?
The global Aortic Aneurysm Market was valued at USD 5.68 billion in 2025.
2. What will be the Aortic Aneurysm Market size by 2034?
The market is projected to reach USD 16.78 billion by 2034.
3. What is the CAGR of the Aortic Aneurysm Market?
The market is expected to grow at a CAGR of 12.78% during the 2026–2034 forecast period.
4. Which segment dominates the Aortic Aneurysm Market?
The abdominal aortic aneurysm segment dominated by type with approximately 58% market share, while aortic stent grafts led the product segment with nearly 68% share.
5. Which region holds the largest share of the Aortic Aneurysm Market?
North America dominated the global market with approximately 41% share in 2025, supported by advanced healthcare infrastructure, strong screening programs, and widespread adoption of minimally invasive vascular procedures.